Neuroglia in Cognitive Reserve

Overview

Journal Mol Psychiatry

Specialties Molecular Biology
Psychiatry

Date 2024 Jul 2

PMID 38956370

Authors

Alexei Verkhratsky

Robert Zorec

Affiliations

Soon will be listed here.

Abstract

The concept of cognitive reserve was born to account for the disjunction between the objective extent of brain damage in pathology and its clinical and intellectual outcome. The cognitive reserve comprises structural (brain reserve) and functional (brain maintenance, resilience, compensation) aspects of the nervous tissue reflecting exposome-driven life-long plasticity, which defines the ability of the brain to withstand aging and pathology. The mechanistic background of this concept was primarily focused on adaptive changes in neurones and neuronal networks. We present arguments favoring the more inclusive view, positing that neuroglia are fundamental for defining the cognitive reserve through homeostatic, neuroprotective, and neurodegenerative mechanisms. Neuroglia are critical for the life-long shaping of synaptically connected neuronal circuits as well as the brain connectome thus defining cognitive reserve. Neuroglial homeostatic and protective physiological responses define brain maintenance and resilience, while neuroglia regenerative capabilities are critical for brain compensation in pathology. Targeting neuroglia may represent an untrodden path for prolonging cognitive longevity.

References

Verkhratsky A, Matteoli M, Parpura V, Mothet J, Zorec R . Astrocytes as secretory cells of the central nervous system: idiosyncrasies of vesicular secretion. EMBO J. 2016; 35(3):239-57. PMC: 4741299. DOI: 10.15252/embj.201592705. View

Abjorsbraten K, Skaaraas G, Cunen C, Bjornstad D, Gullestad Binder K, Bojarskaite L . Impaired astrocytic Ca signaling in awake-behaving Alzheimer's disease transgenic mice. Elife. 2022; 11. PMC: 9352348. DOI: 10.7554/eLife.75055. View

Nave K, Werner H . Ensheathment and Myelination of Axons: Evolution of Glial Functions. Annu Rev Neurosci. 2021; 44:197-219. DOI: 10.1146/annurev-neuro-100120-122621. View

Park J, Ju Y, Choi J, Song H, Jang B, Woo J . Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease. Sci Adv. 2019; 5(3):eaav0316. PMC: 6426469. DOI: 10.1126/sciadv.aav0316. View

Popov A, Brazhe N, Morozova K, Yashin K, Bychkov M, Nosova O . Mitochondrial malfunction and atrophy of astrocytes in the aged human cerebral cortex. Nat Commun. 2023; 14(1):8380. PMC: 10725430. DOI: 10.1038/s41467-023-44192-0. View

Ahangari N, Fischer C, Schweizer T, Munoz D . Cognitive resilience and severe Alzheimer's disease neuropathology. Aging Brain. 2023; 3:100065. PMC: 9997171. DOI: 10.1016/j.nbas.2023.100065. View

Yang Z, Gong M, Jian T, Li J, Yang C, Ma Q . Engrafted glial progenitor cells yield long-term integration and sensory improvement in aged mice. Stem Cell Res Ther. 2022; 13(1):285. PMC: 9241208. DOI: 10.1186/s13287-022-02959-0. View

de Faria Jr O, Gonsalvez D, Nicholson M, Xiao J . Activity-dependent central nervous system myelination throughout life. J Neurochem. 2018; 148(4):447-461. PMC: 6587454. DOI: 10.1111/jnc.14592. View

Yi C, Verkhratsky A, Niu J . Pathological potential of oligodendrocyte precursor cells: terra incognita. Trends Neurosci. 2023; 46(7):581-596. DOI: 10.1016/j.tins.2023.04.003. View

10.

Verkhratsky A, Rodrigues J, Pivoriunas A, Zorec R, Semyanov A . Astroglial atrophy in Alzheimer's disease. Pflugers Arch. 2019; 471(10):1247-1261. DOI: 10.1007/s00424-019-02310-2. View

11.

Kucukdereli H, Allen N, Lee A, Feng A, Ozlu M, Conatser L . Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc Natl Acad Sci U S A. 2011; 108(32):E440-9. PMC: 3156217. DOI: 10.1073/pnas.1104977108. View

12.

Kittner S, White L, Farmer M, Wolz M, Kaplan E, Moes E . Methodological issues in screening for dementia: the problem of education adjustment. J Chronic Dis. 1986; 39(3):163-70. DOI: 10.1016/0021-9681(86)90019-6. View

13.

Stern Y . Cognitive reserve in ageing and Alzheimer's disease. Lancet Neurol. 2012; 11(11):1006-12. PMC: 3507991. DOI: 10.1016/S1474-4422(12)70191-6. View

14.

Simons M, Nave K . Oligodendrocytes: Myelination and Axonal Support. Cold Spring Harb Perspect Biol. 2015; 8(1):a020479. PMC: 4691794. DOI: 10.1101/cshperspect.a020479. View

15.

Verkhratsky A, Nedergaard M . Physiology of Astroglia. Physiol Rev. 2018; 98(1):239-389. PMC: 6050349. DOI: 10.1152/physrev.00042.2016. View

16.

Lin S, Zhou B, Chen B, Jiang R, Li B, Illes P . Electroacupuncture prevents astrocyte atrophy to alleviate depression. Cell Death Dis. 2023; 14(5):343. PMC: 10227075. DOI: 10.1038/s41419-023-05839-4. View

17.

Dringen R, Pfeiffer B, Hamprecht B . Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J Neurosci. 1999; 19(2):562-9. PMC: 6782200. View

18.

Nelson P, Alafuzoff I, Bigio E, Bouras C, Braak H, Cairns N . Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. J Neuropathol Exp Neurol. 2012; 71(5):362-81. PMC: 3560290. DOI: 10.1097/NEN.0b013e31825018f7. View

19.

Paolicelli R, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P . Synaptic pruning by microglia is necessary for normal brain development. Science. 2011; 333(6048):1456-8. DOI: 10.1126/science.1202529. View

20.

Kovacs G, Ferrer I, Grinberg L, Alafuzoff I, Attems J, Budka H . Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathol. 2015; 131(1):87-102. PMC: 4879001. DOI: 10.1007/s00401-015-1509-x. View